학술논문

Activation of the EGFR pathway as a predictor of response in patients (pts) with advanced colorectal cancer (ACC) treated with chemotherapy and bevacizumab with or without cetuximab
Document Type
Journal
Source
CANCER RESEARCH; MAY 1 2009, 69 2p. Supplement: 9
Subject
Language
English
ISSN
15387445